Hi Joy...PARP is to BRCA carriers what Herceptin is to Her2 and Tamoxifen is to ER/PR+ s (HOPEFULLY, its in trials, but Leea's response is pretty telling!). An oversimplification I know, but dont know how to explain it any other way. BRCA carriers are in a similar situation as Her2 ers as far as aggressive disease and recurrence..
I am SO glad Leeas in the trial!
Bug hugs,marcia
|